Type 2 Diabetes Mellitus Therapeutics Market 2022 Type 2 Diabetes Mellitus Therapeutics Market 2022 Haga clic para leer
  • Comentarios

Type 2 Diabetes Mellitus Therapeutics Market 2022

Type 2 Diabetes Mellitus Therapeutics Market 2022

Publicado el en “Negocios”, Idioma — English. 6 páginas.
The current South-East Asia T2DM market contains novel products, including Jardiance, a SGLT-2 inhibitor; Victoza, a GLP-1 receptor agonist; and Januvia, a DPP-4 inhibitor. Más
Suscríbase GRATIS